Detalhe da pesquisa
1.
Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice.
J Transl Med
; 22(1): 14, 2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38172991
2.
Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines.
Cancer Immunol Immunother
; 72(7): 2113-2125, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36820900
3.
Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform-Analysis of Production and Immunogenicity.
Int J Mol Sci
; 24(10)2023 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37240371
4.
Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilities.
Age Ageing
; 51(5)2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35595256
5.
VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice.
Vaccine
; 42(15): 3474-3485, 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38641492
6.
Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection.
Nat Commun
; 15(1): 2349, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38514609
7.
Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization.
iScience
; 26(4): 106457, 2023 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999095
8.
Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant.
Front Immunol
; 14: 1291972, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38124756
9.
The Characteristics of the HIV-1 Env Glycoprotein Are Linked With Viral Pathogenesis.
Front Microbiol
; 13: 763039, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35401460
10.
Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: A cross sectional study.
Life Sci Alliance
; 5(12)2022 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35961779
11.
Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection.
Cell Rep Med
; 3(2): 100523, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35233547
12.
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals.
Viruses
; 13(6)2021 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34204754
13.
Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes.
Med
; 2(3): 313-320.e4, 2021 03 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33554155